Effect of a short-term oral administration of cimetidine and ranitidine on the basal and thyrotropin-releasing hormone-stimulated serum concentrations of prolactin, thyrotropin and thyroid hormones in healthy volunteers. A double-blind cross-over study

Pharmacology. 1986;32(2):101-8. doi: 10.1159/000138157.

Abstract

Cimetidine (400 mg b.d.), ranitidine (150 mg b.d.) and placebo were administered for 1 week to 6 healthy male volunteers in a randomized double-blind cross-over fashion. Hormonal concentrations before and after a TRH test were assessed before and after each treatment. A spontaneous decrease in the hormonal response to TRH was observed after placebo treatment. Both cimetidine and ranitidine induced a significant increase in basal prolactin (PRL) values. Neither TSH nor T3 were modified by cimetidine or by ranitidine. The basal concentration of reverse T3 was increased during cimetidine treatment. There was a significant rise in post-TRH T4 after cimetidine and ranitidine administration. These results suggest a role for histamine H2 receptors in the secretion of PRL and T4. Moreover, cimetidine affects the hepatic metabolism of thyroid hormones.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cimetidine / adverse effects
  • Cimetidine / pharmacology*
  • Double-Blind Method
  • Humans
  • Male
  • Prolactin / blood*
  • Random Allocation
  • Ranitidine / adverse effects
  • Ranitidine / pharmacology*
  • Thyroid Hormones / blood*
  • Thyrotropin / blood*
  • Thyrotropin-Releasing Hormone
  • Triiodothyronine / blood

Substances

  • Thyroid Hormones
  • Triiodothyronine
  • Thyrotropin-Releasing Hormone
  • Cimetidine
  • Ranitidine
  • Prolactin
  • Thyrotropin